Trial
NCT02174263
Tocilizumab for Chronic Graft-versus-Host Disease Treatment
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Fred Hutchinson Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
Graft Versus Host Disease
Intervention
tocilizumab
Why stopped
Study never opened due to lack of funds.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-06